Acción HTGMQ HTG MOLECULAR DIAGNOSTICS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas HTG Molecular Diagnostics, Inc.

Acciones

HTGMQ

US40434H3021

Mercado cerrado - OTC Markets
Otros sitios de cotización
 21:56:26 01/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,0025 USD 0,00 % Gráfico intradía de HTG Molecular Diagnostics, Inc. +66,67 % +92,31 %
2023 Nombramiento de fideicomisario/examinador en virtud del Capítulo 11 para HTG Molecular Diagnostics, Inc. CI
2023 Htg Molecular Diagnostics, Inc. Anuncia el cese de Byron T. Lawson como Vicepresidente Senior y Director Comercial CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Motion for De Minimus Asset Sale Approved for HTG Molecular Diagnostics, Inc.
Motion for De Minimus Asset Sale Filed by HTG Molecular Diagnostics, Inc.
Trustee/Examiner Appointed Under Chapter 11 for HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc.(OTCPK:HTGM.Q) dropped from NASDAQ Composite Index
HTG MOLECULAR DIAGNOSTICS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
HTG Molecular Diagnostics, Inc.(NasdaqCM:HTGM) dropped from S&P TMI Index
Htg Molecular Diagnostics, Inc. Announces Termination of Employment of Byron T. Lawson as Senior Vice President and Chief Commercial Officer
HTG Molecular Diagnostics, Inc. Filed for Bankruptcy
HTG to Highlight the Advantages of its Drug Discovery Engine at the 2023 BIO International Convention
HTG Molecular Diagnostics, Inc. to Highlight the Advantages of its Drug Discovery Engine at the 2023 Biotechnology Innovation Organization
Top Premarket Gainers
HTG Highlights the Advantages of Its Drug Discovery Engine
HTG Molecular Diagnostics : Reports First Quarter 2023 Results and Provides Recent Business Highlights - Form 8-K
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
HTG MOLECULAR DIAGNOSTICS, INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
HTG Molecular Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
HTG MOLECULAR DIAGNOSTICS, INC : Other Events (form 8-K)
HTG Provides Update on Drug Discovery Partnering Initiative
HTG Announces Key First Quarter Milestone Achievements for Drug Discovery
HTG Technology Featured in Numerous Scientific Posters at the AACR Annual Meeting April 16-19
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción HTGMQ
  4. Noticias HTG Molecular Diagnostics, Inc.
  5. Otros idiomas